Get startedLog in
    Picture of Alphamab Oncology logo

    9966 — Alphamab Oncology News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Alphamab Oncology Got Investigational New Drug Approval By Nmpa For A Phase III Clinical Trial Of KN046

    Picture of Alphamab Oncology logoAlphamab Oncology
    23/11/2021 15:28
    Nov 23 (Reuters) - Alphamab Oncology  9966.HK :
    * GOT INVESTIGATIONAL NEW DRUG APPROVAL BY NMPA FOR A PHASE
III
CLINICAL TRIAL OF KN046

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS7ZzGTh
Further company coverage:  9966.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Alphamab Oncology

    See all news